Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17253261 | 0.85 | ALDH1A1 (0.50) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL901254 | 0.78 | ALOX15 (0.53) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL27086 | 0.78 | — | — | |
| SCHEMBL4343290 | 0.77 | ALDH1A1 (0.43) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL1040128 | 0.77 | ALDH1A1 (0.43) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL12109957 | 0.77 | ALDH1A1 (0.54) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL12103657 | 0.77 | ALDH1A1 (0.43) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL16327847 | 0.77 | ALDH1A1 (0.48) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| Acetone SCHEMBL7637226 | 0.76 | ALOX15 (0.52) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| Methane SCHEMBL766234 | 0.76 | ALOX15 (0.52) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180008687-A1 | NANOPARTICLE CONJUGATES OF HIGHLY POTENT TOXINS AND INTRAPERITONEAL ADMINISTRATION OF NANOPARTICLES FOR TREATING OR IMAGING CANCER | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2018-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180008687-A1 | NANOPARTICLE CONJUGATES OF HIGHLY POTENT TOXINS AND INTRAPERITONEAL ADMINISTRATION OF NANOPARTICLES FOR TREATING OR IMAGING CANCER | ANXA4, ANXA3, CD47 | ACHE 878/4885ALOX15 2083/4885ALDH1A1 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.